Successful Treatment of Dercum's Disease by Transcutaneous Electrical Stimulation: A Case Report

Sabina Martinenghi, Amelia Caretto, Claudio Losio, Marina Scavini, Emanuele Bosi

Research output: Contribution to journalArticle

Abstract

Dercum's disease is a rare condition of painful subcutaneous growth of adipose tissue. Etiology is unknown and pain is difficult to control. We report the case of a 57-year-old man with generalized diffuse Dercum's disease, who improved after the treatment with transcutaneous frequency rhythmic electrical modulation system (FREMS). Treatment consisted in 4 cycles of 30 minutes FREMS sessions over a 6-month period. Measures of efficacy included pain assessment (visual analogue scale, VAS), adipose tissue thickness by magnetic resonance imaging, total body composition and regional fat mass by dual-energy X-ray absorptiometry, physical disability (Barthel index), and health status (Short Form-36 questionnaire). After FREMS treatment the patient's clinical conditions significantly improved, with reduction of pain on the VAS scale from 64 to 17 points, improvement of daily life abilities (the Barthel index increased from 12 to 18) and amelioration of health status (higher scores than baseline in all Short Form-36 domains). Furthermore, we documented a 12 mm reduction in subcutaneous adipose tissue thickness at the abdominal wall and a 7040 g decrease in total body fat mass. FREMS therapy proved to be effective and safe in the treatment of this rare and disabling condition.

Original languageEnglish
Pages (from-to)e950
JournalMedicine (United States)
Volume94
Issue number24
DOIs
Publication statusPublished - Jun 1 2015

Fingerprint

Adiposis Dolorosa
Transcutaneous Electric Nerve Stimulation
Subcutaneous Fat
Pain Measurement
Adipose Tissue
Health Status Indicators
Therapeutics
Aptitude
Photon Absorptiometry
Abdominal Wall
Body Composition
Visual Analog Scale
Health Status
Fats
Magnetic Resonance Imaging
Pain
Growth

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Successful Treatment of Dercum's Disease by Transcutaneous Electrical Stimulation : A Case Report. / Martinenghi, Sabina; Caretto, Amelia; Losio, Claudio; Scavini, Marina; Bosi, Emanuele.

In: Medicine (United States), Vol. 94, No. 24, 01.06.2015, p. e950.

Research output: Contribution to journalArticle

@article{d546965799a64f44a4991d274e9fec3c,
title = "Successful Treatment of Dercum's Disease by Transcutaneous Electrical Stimulation: A Case Report",
abstract = "Dercum's disease is a rare condition of painful subcutaneous growth of adipose tissue. Etiology is unknown and pain is difficult to control. We report the case of a 57-year-old man with generalized diffuse Dercum's disease, who improved after the treatment with transcutaneous frequency rhythmic electrical modulation system (FREMS). Treatment consisted in 4 cycles of 30 minutes FREMS sessions over a 6-month period. Measures of efficacy included pain assessment (visual analogue scale, VAS), adipose tissue thickness by magnetic resonance imaging, total body composition and regional fat mass by dual-energy X-ray absorptiometry, physical disability (Barthel index), and health status (Short Form-36 questionnaire). After FREMS treatment the patient's clinical conditions significantly improved, with reduction of pain on the VAS scale from 64 to 17 points, improvement of daily life abilities (the Barthel index increased from 12 to 18) and amelioration of health status (higher scores than baseline in all Short Form-36 domains). Furthermore, we documented a 12 mm reduction in subcutaneous adipose tissue thickness at the abdominal wall and a 7040 g decrease in total body fat mass. FREMS therapy proved to be effective and safe in the treatment of this rare and disabling condition.",
author = "Sabina Martinenghi and Amelia Caretto and Claudio Losio and Marina Scavini and Emanuele Bosi",
year = "2015",
month = "6",
day = "1",
doi = "10.1097/MD.0000000000000950",
language = "English",
volume = "94",
pages = "e950",
journal = "Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries",
issn = "0025-7974",
publisher = "Lippincott Williams and Wilkins",
number = "24",

}

TY - JOUR

T1 - Successful Treatment of Dercum's Disease by Transcutaneous Electrical Stimulation

T2 - A Case Report

AU - Martinenghi, Sabina

AU - Caretto, Amelia

AU - Losio, Claudio

AU - Scavini, Marina

AU - Bosi, Emanuele

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Dercum's disease is a rare condition of painful subcutaneous growth of adipose tissue. Etiology is unknown and pain is difficult to control. We report the case of a 57-year-old man with generalized diffuse Dercum's disease, who improved after the treatment with transcutaneous frequency rhythmic electrical modulation system (FREMS). Treatment consisted in 4 cycles of 30 minutes FREMS sessions over a 6-month period. Measures of efficacy included pain assessment (visual analogue scale, VAS), adipose tissue thickness by magnetic resonance imaging, total body composition and regional fat mass by dual-energy X-ray absorptiometry, physical disability (Barthel index), and health status (Short Form-36 questionnaire). After FREMS treatment the patient's clinical conditions significantly improved, with reduction of pain on the VAS scale from 64 to 17 points, improvement of daily life abilities (the Barthel index increased from 12 to 18) and amelioration of health status (higher scores than baseline in all Short Form-36 domains). Furthermore, we documented a 12 mm reduction in subcutaneous adipose tissue thickness at the abdominal wall and a 7040 g decrease in total body fat mass. FREMS therapy proved to be effective and safe in the treatment of this rare and disabling condition.

AB - Dercum's disease is a rare condition of painful subcutaneous growth of adipose tissue. Etiology is unknown and pain is difficult to control. We report the case of a 57-year-old man with generalized diffuse Dercum's disease, who improved after the treatment with transcutaneous frequency rhythmic electrical modulation system (FREMS). Treatment consisted in 4 cycles of 30 minutes FREMS sessions over a 6-month period. Measures of efficacy included pain assessment (visual analogue scale, VAS), adipose tissue thickness by magnetic resonance imaging, total body composition and regional fat mass by dual-energy X-ray absorptiometry, physical disability (Barthel index), and health status (Short Form-36 questionnaire). After FREMS treatment the patient's clinical conditions significantly improved, with reduction of pain on the VAS scale from 64 to 17 points, improvement of daily life abilities (the Barthel index increased from 12 to 18) and amelioration of health status (higher scores than baseline in all Short Form-36 domains). Furthermore, we documented a 12 mm reduction in subcutaneous adipose tissue thickness at the abdominal wall and a 7040 g decrease in total body fat mass. FREMS therapy proved to be effective and safe in the treatment of this rare and disabling condition.

UR - http://www.scopus.com/inward/record.url?scp=84941363659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941363659&partnerID=8YFLogxK

U2 - 10.1097/MD.0000000000000950

DO - 10.1097/MD.0000000000000950

M3 - Article

C2 - 26091459

VL - 94

SP - e950

JO - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries

JF - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries

SN - 0025-7974

IS - 24

ER -